Jennifer Kayden Lee - Feb 9, 2023 Form 4/A - Amendment Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
EVP, Head of North America
Signature
/s/ Hunter Smith, Attorney-in-Fact for Jennifer Chien
Stock symbol
RYTM
Transactions as of
Feb 9, 2023
Transactions value $
-$33,122
Form type
4/A - Amendment
Date filed
2/14/2023, 06:19 PM
Date Of Original Report
Feb 13, 2023
Previous filing
Feb 3, 2023
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Sale -$33.1K -1.2K -25.36% $27.51 3.54K Feb 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Remarks:

This amended Form 4 is being filed solely for the purpose of correcting an administrative error in the number of shares sold and sale price which were initially reported on the Form 4 filed on February 13, 2023.